Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 7/2020

01.07.2020 | Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Headache in the Older Population: Causes, Diagnoses, and Treatments

verfasst von: Jennifer Robblee, Rashmi Halker Singh

Erschienen in: Current Pain and Headache Reports | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Primary headaches are less common and differ in presentation in older versus younger individuals. Secondary headaches become more common among older patients.

Recent Findings

Diagnosis and management of headaches in those > 65 years are discussed. Migraine and tension-type headaches are rarely new onset in this age group and should be a diagnosis of exclusion. In older individuals, migraine is more likely to be bilateral with less sensory sensitivities. Migraine aura may present without headache; careful assessment is needed to exclude stroke. Other primary headaches discussed include cough, hypnic, and other headaches. Secondary causes discussed include giant cell arteritis, trigeminal post-herpetic neuropathy, sleep apnea, cardiac cephalgia, cervicogenic pain, vascular etiologies, medications, and burning-mouth syndrome.

Summary

In older individuals, primary headaches are diagnoses of exclusion, and treatment is affected by comorbidities and polypharmacy. Secondary headaches are a major consideration requiring appropriate workup. Many treatments can safely be offered regardless of age.
Literatur
1.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.PubMed
2.
Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496–505.PubMed
3.
Feleppa M, Fucci S, Bigal ME. Primary headaches in an elderly population seeking medical care for cognitive decline. Headache. 2017;57(2):209–16.PubMed
4.
Franceschi M, Colombo B, Rossi P, Canal N. Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA). Headache. 1997;37(2):79–82.PubMed
5.
Hale WE, May FE, Marks RG, Moore MT, Stewart RB. Headache in the elderly: an evaluation of risk factors. Headache. 1987;27(5):272–6.PubMed
6.
Hascalovici JR, Robbins MS. Peripheral nerve blocks for the treatment of headache in older adults: a retrospective study. Headache. 2017;57(1):80–6.PubMed
7.
Jensen RH. Tension-type headache - the normal and most prevalent headache. Headache. 2018;58(2):339–45.PubMed
8.
Crystal SC, Robbins MS. Epidemiology of tension-type headache. Curr Pain Headache Rep. 2010;14(6):449–54.PubMed
9.
Wrobel Goldberg S, Silberstein S, Grosberg BM. Considerations in the treatment of tension-type headache in the elderly. Drugs Aging. 2014;31(11):797–804.PubMed
10.
Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996;61(3):285–90.PubMedPubMedCentral
11.
Freund B, Rao A. Efficacy of botulinum toxin in tension-type headaches: a systematic review of the literature. Pain Pract. 2019;19(5):541–51.PubMed
12.
de Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018;58(4):525–33.PubMed
13.
Lisotto C, Mainardi F, Maggioni F, Dainese F, Zanchin G. Headache in the elderly: a clinical study. J Headache Pain. 2004;5(1):36–41.PubMedCentral
14.
Martins KM, Bordini CA, Bigal ME, Speciali JG. Migraine in the elderly: a comparison with migraine in young adults. Headache. 2006;46(2):312–6.PubMed
15.
16.
Wijman CA, Wolf PA, Kase CS, Kelly-Hayes M, Beiser AS. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke. 1998;29(8):1539–43.PubMed
17.
Evans RW, Tietjen GE. Migrainous aura versus transient ischemic attack in an elderly migraineur. Headache. 2001;41(2):201–3.PubMed
18.
Samanci B, Coban O, Baykan B. Late onset aura may herald cerebral amyloid angiopathy: a case report. Cephalalgia. 2016;36(10):998–1001.PubMed
19.
Raskin NH. The hypnic headache syndrome. Headache. 1988;28(8):534–6.PubMed
20.
Holle D, Naegel S, Obermann M. Hypnic headache. Cephalalgia. 2013;33(16):1349–57.PubMed
21.
Holle D, Naegel S, Krebs S, Katsarava Z, Diener HC, Gaul C, et al. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia. 2010;30(12):1435–42.PubMed
22.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
23.
Donnet A, Lanteri-Minet M. A consecutive series of 22 cases of hypnic headache in France. Cephalalgia. 2009;29(9):928–34.PubMed
24.
Holle D, Naegel S, Obermann M. Pathophysiology of hypnic headache. Cephalalgia. 2014;34(10):806–12.PubMed
25.
Holle D, Naegel S, Krebs S, Gaul C, Gizewski E, Diener HC, et al. Hypothalamic gray matter volume loss in hypnic headache. Ann Neurol. 2011;69(3):533–9.PubMed
26.
Lanteri-Minet M. Hypnic headache. Headache. 2014;54(9):1556–9.PubMed
27.
Dodick DW, Jones JM, Capobianco DJ. Hypnic headache: another indomethacin-responsive headache syndrome? Headache. 2000;40(10):830–5.PubMed
28.
Pascual J. Primary cough headache. Curr Pain Headache Rep. 2005;9(4):272–6.PubMed
29.
Pascual J, Gonzalez-Mandly A, Martin R, Oterino A. Headaches precipitated by cough, prolonged exercise or sexual activity: a prospective etiological and clinical study. J Headache Pain. 2008;9(5):259–66.PubMedPubMedCentral
30.
Chen PK, Fuh JL, Wang SJ. Cough headache: a study of 83 consecutive patients. Cephalalgia. 2009;29(10):1079–85.PubMed
31.
Pascual J, Iglesias F, Oterino A, Vazquez-Barquero A, Berciano J. Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology. 1996;46(6):1520–4.PubMed
32.
33.
34.
Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983;26(10):1214–9.PubMed
35.
Smith JH, Swanson JW. Giant cell arteritis. Headache. 2014;54(8):1273–89.PubMed
36.
Gonzalez-Gay MA, Ortego-Jurado M, Ercole L, Ortego-Centeno N. Giant cell arteritis: is the clinical spectrum of the disease changing? BMC Geriatr. 2019;19(1):200.PubMedPubMedCentral
37.
Calderon-Goercke M, Loricera J, Aldasoro V, et al. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. Semin Arthritis Rheum. 2019;49(1):126–35.PubMed
38.
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Glucocorticoid dosages and acute-phase reactant levels at giant cell arteritis flare in a randomized trial of tocilizumab. Arthritis Rheum. 2019;71(8):1329–38.
39.
Lipton RB, Lowenkopf T, Bajwa ZH, Leckie RS, Ribeiro S, Newman LC, et al. Cardiac cephalgia: a treatable form of exertional headache. Neurology. 1997;49(3):813–6.PubMed
40.
Wei JH, Wang HF. Cardiac cephalalgia: case reports and review. Cephalalgia. 2008;28(8):892–6.PubMed
41.
Lazari J, Money-Kyrle A, Wakerley BR. Cardiac cephalalgia: severe, non-exertional headache presenting as unstable angina. cepPract Neurol. 2019;19(2):173–5.
42.
Mathew PG, Boes CJ, Garza I. A tale of two systems: cardiac cephalalgia vs migrainous thoracalgia. Headache. 2015;55(2):310–2.PubMed
43.
Feller L, Khammissa RAG, Fourie J, Bouckaert M, Lemmer J. Postherpetic neuralgia and trigeminal neuralgia. Pain Res Treat. 2017;2017:1681765.PubMedPubMedCentral
44.
Johnson RW, Rice ASC. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–33.PubMed
45.
Amicizia D, Domnich A, Arata L, Zoli D, Zotti CM, Cacello E, et al. The role of age-sex interaction in the development of post-herpetic neuralgia. Hum Vaccin Immunother. 2017;13(2):376–8.PubMedPubMedCentral
46.
Alicino C, Trucchi C, Paganino C, Barberis I, Boccalini S, Martinelli D, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13(2):399–404.PubMed
47.
Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30–54.PubMed
48.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88.PubMed
49.
Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins. 2017;9(9):260.PubMedCentral
50.
BoTN-A: The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Brit Dent J. 2016;221(8):475.
51.
Ulfberg J, Carter N, Talbäck M, Edling C. Headache, snoring and sleep apnoea. J Neurol. 1996;243(9):621–5.PubMed
52.
53.
54.
Chung F, Abdullah HR, Liao P. STOP-bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.PubMed
55.
Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009;8(10):959–68.PubMed
56.
Fredriksen TA, Antonaci F, Sjaastad O. Cervicogenic headache: too important to be left un-diagnosed. J Headache Pain. 2015;16:6.PubMedPubMedCentral
57.
Shimohata K, Hasegawa K, Onodera O, Nishizawa M, Shimohata T. The clinical features, risk factors, and surgical treatment of cervicogenic headache in patients with cervical spine disorders requiring surgery. Headache. 2017;57(7):1109–17.PubMed
58.
Hogg-Johnson S, van der Velde G, Carroll LJ, Holm LW, Cassidy JD, Guzman J, et al. The burden and determinants of neck pain in the general population: results of the bone and joint decade 2000-2010 task force on neck pain and its associated disorders. Spine. 2008;33(4 Suppl):S39–51.PubMed
59.
60.
Chaibi A, Russell MB. Manual therapies for cervicogenic headache: a systematic review. J Headache Pain. 2012;13(5):351–9.PubMedPubMedCentral
61.
Nagar VR, Birthi P, Grider JS, Asopa A. Systematic review of radiofrequency ablation and pulsed radiofrequency for management of cervicogenic headache. Pain Phys. 2015;18(2):109–30.
62.
Linde M, Hagen K, Salvesen O, Gravdahl GB, Helde G, Stovner LJ. Onabotulinum toxin a treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. Cephalalgia. 2011;31(7):797–807.PubMed
63.
Gross AR, Paquin JP, Dupont G, Blanchette S, Lalonde P, Cristie T, et al. Exercises for mechanical neck disorders: a Cochrane review update. Man Ther. 2016;24:25–45.PubMed
64.
Oliveira FAA, Sampaio Rocha-Filho PA. Headaches attributed to ischemic stroke and transient ischemic attack. Headache. 2019;59(3):469–76.PubMed
65.
Pollak L, Shlomo N, Korn LI. Headache in stroke according to National Acute Stroke Israeli Survey. Acta Neurol Scand. 2017;135(4):469–75.PubMed
66.
Aktan C, Ozgur O, Sindel T, Dora B. Characteristics of headache during and after digital substraction angiography: a critical re-appraisal of the ICHD-3 criteria. Cephalalgia. 2017;37(11):1074–81.PubMed
67.
Toth C. Medications and substances as a cause of headache: a systematic review of the literature. Clin Neuropharmacol. 2003;26(3):122–36.PubMed
68.
Evans RW, Drage LA. Burning mouth syndrome. Headache. 2005;45(8):1079–81.PubMed
69.
Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain. 2004;108(1–2):51–7.PubMed
Metadaten
Titel
Headache in the Older Population: Causes, Diagnoses, and Treatments
verfasst von
Jennifer Robblee
Rashmi Halker Singh
Publikationsdatum
01.07.2020
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 7/2020
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-020-00866-8

Weitere Artikel der Ausgabe 7/2020

Current Pain and Headache Reports 7/2020 Zur Ausgabe

Other Pain ( AD Kaye and N Vadivelu, Section Editors)

Gut Microbiome Dysbiosis and Depression: a Comprehensive Review

Other Pain (AD Kaye and N Vadivelu, Section Editors)

Considerations and Implications of Cannabidiol Use During Pregnancy

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Headache in Ruptured Intracranial Dermoid Cysts

Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)

Fear, Avoidance, and Disability in Headache Disorders

Other Pain (AD Kaye and N Vadivelu, Section Editors)

Minimally Invasive Therapies for Osteoarthritic Hip Pain: a Comprehensive Review

Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)

Acupuncture for Migraine: a Review of the Data and Clinical Insights

Neu im Fachgebiet AINS

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Schlaganfall: frühzeitige Blutdrucksenkung im Krankenwagen ohne Nutzen

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise